European Journal of Medicinal Chemistry, volume 37, issue 1, pages 83-89
2-Arylalkyl-substituted anthracenones as inhibitors of 12-lipoxygenase enzymes. 2. Structure–activity relationships of the linker chain
Klause Muller
1
,
Reinhold Altmann
2
,
Helge Prinz
3
2
Publication type: Journal Article
Publication date: 2002-01-01
scimago Q1
wos Q1
SJR: 1.151
CiteScore: 11.7
Impact factor: 6
ISSN: 02235234, 17683254
PubMed ID:
11841878
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Abstract
A series of 2-arylalkyl-substituted anthracenones were tested as inhibitors of three types of 12-lipoxygenase isoforms in epidermal homogenate of mice, bovine platelets and porcine leukocytes. Their inhibitory activities were compared with those to inhibit the 5-lipoxygenase enzyme in bovine leukocytes. The compounds were synthesised by Marschalk, Wittig or Horner–Emmons reaction at the anthracenedione stage and then reduced to the anthracenones. Structure–activity relationship for the chain linking the anthracenone nucleus and the phenyl ring terminus was investigated. The 2-phenylethyl analogues were among the most potent inhibitors, and 3,4-dimethoxy-substituted 10f was identified as a selective inhibitor of the 12-LO enzymes over 5-LO. Selectivity for 12-LO isoforms was observed with an increase in the overall lipophilicity of the inhibitors. However, none of the linker chains of the 2-substituted anthracenones provided inhibitors that were able to discriminate between the 12-LO isoforms.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.